Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis

The prognostic value, in active ulcerative colitis, of an increased intensity of colonic perivisceral fat signal on magnetic resonance imaging with ferumoxil

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2001.03531.x ◽

2001 ◽

Vol 96 (2) ◽

pp. 481-486 ◽

Cited By ~ 6

Author(s):

Agesilao D'Arienzo ◽

Giuseppe Scaglione ◽

Raffaele Bennato ◽

Francesco Manguso ◽

Giovanni Vicinanza ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Ulcerative Colitis ◽

Magnetic Resonance ◽

Prognostic Value ◽

Resonance Imaging

PROGNOSTIC VALUE OF THE MAGNITUDE OF CYTOMEGALOVIRUS REACTIVATION EVALUATED BY IMMUNOHISTOCHEMICAL STAINING IN PATIENTS WITH ULCERATIVE COLITIS.

10.26226/morressier.57c5383cd462b80296c9b08e ◽

2016 ◽

Author(s):

Eugeni Domènech

Keyword(s):

Ulcerative Colitis ◽

Immunohistochemical Staining ◽

Prognostic Value ◽

Cytomegalovirus Reactivation

Phase II study of safety, efficacy and pharmacokinetics of BXT-51072 in patients with mild-moderately active ulcerative colitis

Gastroenterology ◽

10.1016/s0016-5085(01)81390-1 ◽

2001 ◽

Vol 120 (5) ◽

pp. A280-A280

Author(s):

S HANAUER ◽

P MINER ◽

A KESHAVARZIAN ◽

E MORRIS ◽

B SALZBERG ◽

...

Keyword(s):

Ulcerative Colitis ◽

Phase Ii ◽

Phase Ii Study ◽

Randomised clinical trial: early assessment after 2weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question

Yearbook of Medicine ◽

10.1016/s0084-3873(11)00325-7 ◽

2011 ◽

Vol 2011 ◽

pp. 450-451

Author(s):

M.F. Picco

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Randomised Clinical Trial ◽

High Dose ◽

Early Assessment

Natural supplementary treatment and element content in erythrocytes of patients with moderately active ulcerative colitis

Zeitschrift für Gastroenterologie ◽

10.1055/s-2007-982734 ◽

2007 ◽

Vol 45 (05) ◽

Author(s):

K Szentmihályi ◽

Á Kovács ◽

E Rapavi ◽

L Váli ◽

A Blázovics

Keyword(s):

Ulcerative Colitis ◽

Element Content ◽

Supplementary Treatment

ACTIVE ULCERATIVE COLITIS IS CHARACTERIZED BY ΤΗΕ FORMATION OF THROMBOGENIC TISSUE FACTOR-EXPRESSING NEUTROPHIL EXTRACELLULAR TRAPS

10.26226/morressier.59a6b343d462b80290b543ce ◽

2017 ◽

Author(s):

Akrivi Chrysanthopoulou

Keyword(s):

Ulcerative Colitis ◽

Tissue Factor ◽

Neutrophil Extracellular Traps ◽

Extracellular Traps

GB004 in Adult Subjects With Active Ulcerative Colitis

Case Medical Research ◽

10.31525/ct1-nct03860896 ◽

2019 ◽

Author(s):

Keyword(s):

Ulcerative Colitis ◽

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

Case Medical Research ◽

10.31525/ct1-nct03996369 ◽

2019 ◽

Author(s):

Keyword(s):

Ulcerative Colitis ◽

Induction Therapy ◽

FMT for Remission of Active Ulcerative Colitis in Adults

Case Medical Research ◽

10.31525/ct1-nct04202211 ◽

2019 ◽

Author(s):

Keyword(s):

Ulcerative Colitis ◽

Faculty Opinions recommendation of Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954978.793464633 ◽

2012 ◽

Author(s):

Severine Vermeire

Keyword(s):

Ulcerative Colitis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Janus Kinase Inhibitor